Lv1
20 积分 2024-07-31 加入
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
8个月前
已完结
Sa1366 EFFICACY OF 7-DAY AND 10-DAY OF VAB (VONOPRAZAN, AMOXICILLIN, AND BISMUTH SUBSALICYLATE) VERSUS 14-DAY STANDARD TRIPLE THERAPY FOR FIRST-LINE HELICOBACTER PYLORI ERADICATION: A MULTICENTER RANDOMIZED CONTROLLED TRIAL
8个月前
已完结
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea
9个月前
已完结
Safety of Quinolones in Children: A Systematic Review and Meta-Analysis
9个月前
已完结
皖公网安备34019202002308
